Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: A randomized phase III study (ALLY-3+) - Leroy, V; Angus, P; Bronowicki, J P (Hepatology, 2016)
et al.